Genisphere: Genisphere Reports Safety of 3DNA Nanocarrier
The study demonstrated no adverse clinical findings after repeated intravenous administration of the maximum achievable dose of 3DNA nanocarrier.
Read full article »
Genisphere research and development service for the nanotechnology based products.
Read more